The latest myeloma news
FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma
The Food and Drug Administration (FDA) approved daratumumab and hyaluronidase-fihj for adult patients with newly…
The latest myeloma news
The Food and Drug Administration (FDA) approved daratumumab and hyaluronidase-fihj for adult patients with newly…
Researchers use single-cell RNA sequencing to map changes in immune microenvironment in myeloma precursor conditions;…
A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may…
A study published in the journal Oncotarget has reported that in order to understand the molecular mechanism…
A new genetic test could help doctors pick out patients with the bone marrow cancer…
Today, the U.S. Food and Drug Administration (FDA) approved isatuximab-irfc, in combination with pomalidomide and…
Too many patients with cancers like multiple myeloma relapse after treatment. This grim reality motivated…
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially…
Adding daratumumab to carfilzomib and dexamethasone to treat patients with relapsed or refractory multiple myeloma…
The phase 3 ALCYONE study showed the addition of daratumumab to bortezomib, melphalan and prednisone (D-VMP) improved…